L322-0385 Screening compound: N-[1,3-dimethyl-6-(4-methylbenzenesulfonyl)-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-3-methylthiophene-2-carboxamide

L322-0385 Screening compound: N-[1,3-dimethyl-6-(4-methylbenzenesulfonyl)-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-3-methylthiophene-2-carboxamide
L322-0385 Screening compound: N-[1,3-dimethyl-6-(4-methylbenzenesulfonyl)-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-3-methylthiophene-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L322-0385
N-[1,3-dimethyl-6-(4-methylbenzenesulfonyl)-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-3-methylthiophene-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L322-0385

Molecular Formula

C22H21N3O4S2 (C22 H21 N3 O4 S2)

Compound Name

N-[1,3-dimethyl-6-(4-methylbenzenesulfonyl)-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-3-methylthiophene-2-carboxamide

IUPAC name

N-[13-dimethyl-6-(4-methylbenzenesulfonyl)-2-oxo-23-dihydro-1H-13-benzodiazol-5-yl]-3-methylthiophene-2-carboxamide

SMILES

Cc1c(C(Nc(cc(c(N2C)c3)N(C)C2=O)c3S(c2ccc(C)cc2)(=O)=O)=O)scc1

InChI

InChI=1S/C22H21N3O4S2/c1-13-5-7-15(8-6-13)31(28,29)19-12-18-17(24(3)22(27)25(18)4)11-16(19)23-21(26)20-14(2)9-10-30-20/h5-12H,1-4H3,(H,23,26)

InChI Key

UTHJGWQDCGWVCE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27244961

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

455.56

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.279

Distribution Coefficient, logD

4.274

Water Solubility, LogSw

-4.27

Polar Surface Area

70.836

Acid Dissociation Constant (pKa)

9.31

Base Dissociation Constant (pKb)

-3.07

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

18.20

L322-0385 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Antiviral Library (67538 compounds)

Hsp90-Targeted Library (11355 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Antibacterial Compounds Library (13827 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Infections
  • Immune system
  • animal
Targets:
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with L322-0385 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L322-0385?
Check Price and Availability of L322-0385, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L322-0385 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L322-0385
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L322-0385
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L322-0385 available by request